High-resolution NGS-based HLA typing system that supports multiple sequencing platforms and offers maximum workflow flexibility.

Detailed Description

HLA-SuBiTo NGStype® is a comprehensive solution for high-resolution HLA typing based on next-generation sequencing (NGS), developed by inno-train Diagnostik. The system allows the simultaneous analysis of up to 11 HLA loci using a long-range PCR approach, compatible with multiple library preparation methods and sequencers.

The technology adapts to both short- and long-read sequencers, including Illumina, Oxford Nanopore Technologies (ONT), and MGI. This gives the user complete freedom to choose the sequencing platform according to their infrastructure or analysis needs.

The workflow begins with a long-range PCR covering the HLA-A, -B, -C, -DPA1, -DPB1, -DQA1, -DQB1, and DRB1/3/4/5 loci, with amplicons ranging from 3.4 to 7.4 kb. Analysis quality is guaranteed by the use of specific primers and an optimized master mix included in the kit.

Depending on the chosen workflow, the process can be adapted for laboratories analyzing from a single sample (using ONT’s MinION) up to hundreds of samples in parallel (using MiSeq, MiniSeq, iSeq, among others). Flexibility is one of its main advantages, along with the system’s scalability.

HLA-SuBiTo NGStype PCR Loci

Library preparation can be performed with validated third-party kits such as NEBNext UltraExpress™ for Illumina or Rapid Barcoding Kit for ONT, and the launch of a proprietary library preparation kit by inno-train is anticipated.

Data analysis is performed using NGStype® software, compatible with fastq files from any platform. This software includes optimized algorithms for short- and long-read sequences, allowing automatic haplotype analysis and clear visualization of results.

NGStype Software

Key Features

High-resolution HLA typing for 11 loci.
Long-range PCR with specific primers included.
Compatible with Illumina, ONT, and MGI.
Optimized workflows for low or high sample volumes.
Automated data analysis with NGStype® software.
High data quality (>Q30) and full coverage per locus.
Validated library preparation for multiple commercial kits.
Fast sequencing possible from 20 minutes (MinION).

Ordering Information

Kit name: HLA-SuBiTo NGStype® – 11 loci Contents: reagents for long-range PCR amplification (primers + master mix) Compatibility:
Illumina: validated workflows for MiSeq, iSeq, MiniSeq ONT: validated workflows with Rapid Barcoding Kit and MinION (FLO-MIN114) MGI: compatible (information under development)
Software: NGStype® (automated data analysis) No. of samples per kit: 24 samples – Ref. 002 099 024 Additional requirements: library preparation kits (NEB or ONT), NGS sequencer

Area:

High resolution HLA typing, Immunology, Pre transplantation

Brand:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

Franklin by QIAGEN for Somatic Analysis

Advanced cloud-based bioinformatics platform designed for the automated analysis, interpretation, and classification of somatic variants in oncology. Through an integrated environment, the system evaluates clinical evidence in real time, automates classification in accordance with AMP/ASCO/CAP guidelines, and provides access to currently active clinical trials. Detailed description Operating principle End-to-end cloud-based solution for the clinical interpretation…
Qiagen
Next Generation Sequencing (NGS)

SeqOne Genomics – Somatic

SeqOne is a bioinformatics platform for NGS data analysis in precision oncology, designed to detect, prioritise and interpret somatic variants and generate actionable clinical reports from raw sequencing data. It helps laboratories and healthcare professionals accelerate the interpretation of NGS data through an end-to-end workflow. Detailed description Operating principle SeqOne Genomics is a genomic data…
SeqOne
Next Generation Sequencing (NGS)

MSK-ACCESS® powered with SOPHiA DDM™

In-house liquid biopsy solution based on hybrid-capture next-generation sequencing (NGS) technology for the ultrasensitive detection of somatic alterations in circulating cell-free DNA from plasma. Developed in collaboration with Memorial Sloan Kettering Cancer Center (MSK), it implements a robust matched tumor-normal sequencing approach (plasma cfDNA + white blood cell DNA) to filter germline variants and mutations…
SOPHIA Genetics
Next Generation Sequencing (NGS)

MSK-IMPACT® / MSK-IMPACT® FLEX

Decentralised, in-house comprehensive genomic profiling (CGP) solution for solid tumours, based on hybrid capture next-generation sequencing (NGS). Developed in collaboration with Memorial Sloan Kettering Cancer Center (MSK), it features a robust matched tumour-normal sequencing approach for filtering germline variants and clonal haematopoiesis. Detailed description Operating principle The decentralised MSK-IMPACT® powered with SOPHiA DDM™ solution enables…
SOPHIA Genetics
Next Generation Sequencing (NGS)